Migraine
Conditions
Interventions
Acupuncture
Traditional Migraine Treatment
Sponsors
Saitama Medical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Subjects who have been treated with CGRP-related drugs for more than three months (2) Subjects who have been diagnosed with migraine by a specialist from the Japanese Headache Society (3) Subjects who are able to visit the hospital as outpatients during the treatment and observation period (4) Subjects who have received oral and written explanations regarding participation in this study and have given their consent (5) Subjects who are aged between 18 and 80 at the time of obtaining consent
Exclusion criteria
Exclusion criteria: (1) Patients suspected of having secondary headaches (2) Patients who have difficulty receiving acupuncture treatment due to metal allergies, etc. (3) Patients with significant impairment of major organ function, such as liver function, kidney function, lung function, or hemopoietic and hemostatic functions (4) Pregnant women or women who may be pregnant (5) Patients with psychiatric disorders or symptoms that are deemed difficult to understand regarding clinical trials (6) Patients who are otherwise deemed inappropriate by the physicians who are co-investigators of the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The change in the average number of migraine days per month before and after treatment and observation will be compared between groups. | — |
Secondary
| Measure | Time frame |
|---|---|
| Comparison of mean changes in MIBS-4, MIDAS, HIT-6, VAS, and SF-36 before and after treatment and observation in each group | — |
Countries
Japan
Contacts
Public ContactShintaro Ibata
Saitama Medical University Oriental medicine of Internal Medicine
Outcome results
None listed